Published December 27, 2016 | Version v1
Patent Open

Treatment with opioid antagonists and mTOR inhibitors

  • 1. University of Chicago

Contributors

Patent applicant:

Description

Embodiments of the invention provide methods of treating a disorder or disease characterized by cellular proliferation and migration by co-administering a synergistically effective amount of an mTOR inhibitor and a μ-opioid receptor antagonist.

Files

US9526723.pdf

Files (2.2 MB)

Name Size Download all
md5:41bd0e10c60f88fb7228573bf214aa63
2.2 MB Preview Download

Additional details

Identifiers

Patent application number
US 201414179095 A
Patent number
US 9526723 B2
Other
oai:uchicago.tind.io:8151

Dates

Patent filed
2014-02-12

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Anesthesia and Critical Care